Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
Flanagan KC, Earls J, Schillebeeckx I, Hiken J, Wellinghoff RL, LaFranzo NA, Bradley ZS, Babbitt J, Westra WH, Hsu R, Nadauld L, Mcleod H, Firth SD, Sharp B, Fuller J, Vavinskaya V, Sutton L, Deichaite I, Bailey SD, Sandulache VC, Rendo MJ, Macdonald OK, Welaya K, Wade JL 3rd, Pippas AW, Slim J, Bank B, Saccaro SJ, Sui X, Akhtar A, Balaraman S, Kossman SE, Sonnier SA, Shenkenberg TD, Alexander WL, Price KA, Bane CL, Ley J, Messina DN, Glasscock JI, Cohen EEW, Adkins DR, Duncavage EJ. Flanagan KC, et al. Among authors: sutton l. J Cancer Res Clin Oncol. 2023 Nov;149(15):14125-14136. doi: 10.1007/s00432-023-05205-z. Epub 2023 Aug 8. J Cancer Res Clin Oncol. 2023. PMID: 37552307 Free PMC article.
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Flanagan KC, Earls J, Hiken J, Wellinghoff RL, Ponder MM, McLeod HL, Westra WH, Vavinskaya V, Sutton L, Deichaite I, Macdonald OK, Welaya K, Wade J 3rd, Azzi G, Pippas AW, Slim J, Bank B, Sui X, Kossman SE, Shenkenberg TD, Alexander WL, Price KA, Ley J, Messina DN, Glasscock JI, Colevas AD, Cohen EEW, Adkins D, Duncavage EJ. Flanagan KC, et al. Among authors: sutton l. J Immunother Cancer. 2024 Nov 3;12(11):e009573. doi: 10.1136/jitc-2024-009573. J Immunother Cancer. 2024. PMID: 39489541 Free PMC article.
The Adelaide Score: prospective implementation of an artificial intelligence system to improve hospital and cost efficiency.
Kovoor JG, Stretton B, Gupta AK, Beath A, Jacob MO, Kefalianos JM, Carmichael GJ, Zaka A, O'Callaghan G, Satheakeerthy S, Booth A, Delloso T, Hugh TJ, Chan WO, Maddern GJ, Balan-Vnuk E, Cusack M, Gilbert T, Maddison J, Bacchi S; Adelaide Score Advisory Group. Kovoor JG, et al. ANZ J Surg. 2025 Jan 3. doi: 10.1111/ans.19383. Online ahead of print. ANZ J Surg. 2025. PMID: 39754371
Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States.
Kumar A, Owen JR, Sloat NT, Maynard E, Hill VM, Hubbard CB, McKinney MS, Sutton LM, McCall SJ, Datto MB, Moyer AN, Caughey BA, Strickler JH, Ramaker RC. Kumar A, et al. Among authors: sutton lm. Curr Oncol. 2024 Nov 16;31(11):7244-7257. doi: 10.3390/curroncol31110534. Curr Oncol. 2024. PMID: 39590164 Free PMC article.
918 results